StockData
Cullinan Therapeutics, Inc. logo

Cullinan Therapeutics, Inc. (CGEM) stock

CGEMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$9.28−0.22 (-2.37%)

Close on Nov 17, 2026Market cap $596.89MP/E –Yield –

Cullinan Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Cullinan Therapeutics's market cap was $730.32M on Nov 11, 2026, against $671.70M a year earlier. Over the last 5 years it ranged from $350.21M to $1.42B, with a median of $603.36M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$730.32M+19.4%
2025Dec 31, 2025$611.44M-13.7%
2024Dec 31, 2024$708.16M+62.5%
2023Dec 29, 2023$435.73M-9.7%
2022Dec 30, 2022$482.59M-28.4%
2021Dec 31, 2021$673.69M–

More Cullinan Therapeutics figures

See a number that looks wrong?